Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...

Key findings include: These results suggest that AMBLE may significantly reduce fall risks in stroke patients by improving gait mechanics and functional mobility. REACH: An upper extremity ...

The program is designed to assess the safety and effectiveness of the PoNS device, a non-invasive therapy aimed at improving balance and gait in stroke survivors. Helius plans to submit for FDA ...

because it can help to combat the risks of heart disease and stroke. But a group of researchers found that how someone’s gait (their walking style and speed) looks decades earlier than that may ...

Secondary outcomes included performance on a gait speed test, Barthel Index (BI), NIH Stroke Scale score (NIHSS), Fluid-attenuated inversion recovery (FLAIR) MRI, resting state fMRI and ...

In individuals with chronic stroke, intermittent pneumatic compression (IPC) therapy improved performance in some functional ...

MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation and motor function in adults with Parkinson's disease (PD), has been listed as a Class ...

Gait impairment and loss of motor function are ... therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinson's disease. The company's product ...